medline.ch Onkologie Gynäkologische Tumoren

	Artificial Intelligence in Breast Cancer Lymph Node Evaluation: Is Neoadjuvant Chemotherapy the Achilles' Heel? Arch Pathol Lab Med Aziz M, Sahay A, Hung IC, Khedkar R, Desai SB, Kaushal RK. PMID: 42107972 [PubMed - as supplied by publisher]
	INTEGRATED ANALYSIS OF ERÎ‘, TP53, AND PGR PROTEINS WITH MIR-372, MIR-373, AND MIR-519D DYSREGULATION IN FEMALE BREAST CANCER. Georgian Med News Hassan M, Al-Askeri M. PMID: 42107952 [PubMed - indexed for MEDLINE]
	The role and therapeutic potential of protein glycosylation in the immune regulation of breast cancer. Biochim Biophys Acta Rev Cancer Huang C, Liu H, Ming J. PMID: 42107556 [PubMed - as supplied by publisher]
	Overcoming Breast Cancer Resistance through Targeted Protein Degradation and Next Generation Chimeras. Pharmacol Res Wang X, Song J, Zhao Y, Li W, Li J, Xu X, Liu W, Tao F, Xu Y. PMID: 42107508 [PubMed - as supplied by publisher]
	A systematic review and meta-analysis of medical image-based artificial intelligence models for predicting metastasis in ovarian cancer. Eur J Obstet Gynecol Reprod Biol Xiang L, Li Y, Li M, Qi X. PMID: 42107239 [PubMed - as supplied by publisher]
	An 8-gene diabetes-related signature predicts survival and immunotherapy response in breast cancer. Clinics (Sao Paulo) Jiang X, Yin J, Tong Y, Li J, Ren X, Zhu C. PMID: 42107133 [PubMed - as supplied by publisher]
	Comparative oncology of male and female breast cancer: diagnostic paradigms and machine learning approaches in treatment. J Basic Clin Physiol Pharmacol Das J, Bhui U, Chakraborty GS, Mazumder D, Shil S, Sah AK, Akter B, Hossain J, Nayak S, Basak S, Debnath B, Nath R, Belagodu Sridhar S, Panigrahy UP. PMID: 42107075 [PubMed - as supplied by publisher]
	Tumor ecology and the paradox of clean margins in multicentric breast cancer: an exploratory organoid-based functional study. Breast Cancer Res Martínez-Illescas NG, Martín-Zapater E, Quezada-Gutiérrez C, Yébenes L, Payo-Payo A, Frías-Aldeguer L, Salazar-Roa M. PMID: 42106758 [PubMed - as supplied by publisher]
	Evaluating immunoreactivity of hybridoma-derived antibody mixtures generated against AU-565 cell line for diagnosis and immunotherapy of breast cancer. BMC Cancer Ihlamur M, Demi, Zorba AP, Abamor E, Ba, Allahverdi. PMID: 42106673 [PubMed - as supplied by publisher]
	Integrated Magnetophoretic-Electrochemical platforms for portable detection of HER2 in breast cancer diagnosis. Biosens Bioelectron Anekrattanasap A, Park J, Villarini N, Fukana N, Rai AJ, Siangproh W, Baldo TA, Henry CS. PMID: 42105575 [PubMed - as supplied by publisher]
	Factors influencing information overload among breast cancer patients in the information explosion era: a cross-sectional study. Support Care Cancer Wei J, Liu E, Xie J, Wang P, Bai Z, Jiang H, Xiong Y, Bai L, Zhou J. PMID: 42105010 [PubMed - indexed for MEDLINE]
	Causal Interplay Between Inflammatory Cytokines and Lipid Metabolites in Serous Ovarian Carcinoma: Insights From a Genetic Association Study. J Clin Lab Anal Yang CZ, Qin LH, Huang CC, Huang XL, Yang YX, Lan W, Fan M. PMID: 42104642 [PubMed - as supplied by publisher]
	The RESILIENT Study: A Retrospective, Descriptive, Correlational Investigation of Correlates of Oral Endocrine Therapy Adherence in Older Women With Breast Cancer. Cancer Med Ruggeri SY, Russell Lippincott CL, Alexander GL, Bartlett Ellis RJ, Chesnut SR, Erickson LA. PMID: 42104589 [PubMed - indexed for MEDLINE]
	The risk of ovarian malignancy algorithm for ovarian cancer in premenopausal and postmenopausal women: A systematic review and meta-analysis. Women Health Zhong D, Li J, Guo G. PMID: 42104563 [PubMed - as supplied by publisher]
	Leveraging immune and clinicopathological profiles with machine learning to predict axillary lymph node metastasis in breast cancer patients. Breast Cancer Res Fischer-Carles A, Fiorin A, López Pablo C, Reverté L, Sauras-Colón E, Gallardo-Borràs N, Lejeune M, Relloso Ortiz de Uriarte M, Sánchez-Alcántara T, Ballester-Navarro M, Bosch Príncep R, Adalid-Llansa L, Goyda E, Mata Cano D, Noailly J, Piella G. PMID: 42104431 [PubMed - as supplied by publisher]
	Omission of completion axillary dissection in clinically node-negative breast cancer with 1-2 metastatic sentinel lymph nodes. World J Surg Oncol Qiao W, Guo X, Li P, Liu Q, Deng M. PMID: 42104353 [PubMed - as supplied by publisher]
	Likelihood of breast cancer among women presenting with breast-related symptoms in primary care, with a focus on isolated mastalgia: a retrospective cohort study. BMC Prim Care van Ieperen SKL, van de Laar FA, Akkermans RP, A Uijen A. PMID: 42104316 [PubMed - as supplied by publisher]
	Severe anemia as a risk factor in Japanese patients with ovarian cancer receiving olaparib: a retrospective study. BMC Cancer Yamaoka K, Kume M, Matsumoto A, Hirabatake M, Hayashi N, Shimizu T, Aoki T, Muroi N. PMID: 42104280 [PubMed - as supplied by publisher]
	Ensemble machine learning algorithms leveraged on serum proteomics for enhanced early detection of ovarian cancer. Sci Rep Ding J, Dong X, Cao L, Zhao L, Ding J, Wang B, Li Y, Liu Z, Han L, Li W, Zhang W, Wang X, Guo B, Huang C, Li X, Guo A, Song L. PMID: 42103875 [PubMed - as supplied by publisher]
	Commentary on Editorial: Omitting Radiation for Breast Cancer Patients Eligible for the NSABP B51 Trial Who Achieve ypN0 After Neoadjuvant Chemotherapy. Pract Radiat Oncol Haffty BG. PMID: 42103409 [PubMed - in process]

Artikel 1 - 20 / 328410

Seite 1 von 16421

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung